nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—systemic lupus erythematosus	0.411	1	CbGaD
Nepafenac—PTGS2—Dapsone—systemic lupus erythematosus	0.117	0.257	CbGbCtD
Nepafenac—PTGS2—Triamcinolone—systemic lupus erythematosus	0.101	0.223	CbGbCtD
Nepafenac—PTGS1—Dapsone—systemic lupus erythematosus	0.0986	0.217	CbGbCtD
Nepafenac—PTGS2—Betamethasone—systemic lupus erythematosus	0.0869	0.191	CbGbCtD
Nepafenac—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0505	0.111	CbGbCtD
Nepafenac—Corneal thinning—Dexamethasone—systemic lupus erythematosus	0.00346	0.0293	CcSEcCtD
Nepafenac—Corneal thinning—Betamethasone—systemic lupus erythematosus	0.00346	0.0293	CcSEcCtD
Nepafenac—Vitreous detachment—Dexamethasone—systemic lupus erythematosus	0.00285	0.0242	CcSEcCtD
Nepafenac—Vitreous detachment—Betamethasone—systemic lupus erythematosus	0.00285	0.0242	CcSEcCtD
Nepafenac—Ulcerative keratitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00238	0.0202	CcSEcCtD
Nepafenac—Corneal oedema—Dexamethasone—systemic lupus erythematosus	0.00223	0.0189	CcSEcCtD
Nepafenac—Corneal oedema—Betamethasone—systemic lupus erythematosus	0.00223	0.0189	CcSEcCtD
Nepafenac—Ulcerative keratitis—Prednisolone—systemic lupus erythematosus	0.00222	0.0188	CcSEcCtD
Nepafenac—Rheumatoid arthritis—Cyclosporine—systemic lupus erythematosus	0.00204	0.0173	CcSEcCtD
Nepafenac—Sensation of foreign body—Cyclosporine—systemic lupus erythematosus	0.00189	0.016	CcSEcCtD
Nepafenac—Eye swelling—Cyclosporine—systemic lupus erythematosus	0.00189	0.016	CcSEcCtD
Nepafenac—Sensation of foreign body—Prednisolone—systemic lupus erythematosus	0.00172	0.0146	CcSEcCtD
Nepafenac—Conjunctival oedema—Betamethasone—systemic lupus erythematosus	0.00169	0.0143	CcSEcCtD
Nepafenac—Conjunctival oedema—Dexamethasone—systemic lupus erythematosus	0.00169	0.0143	CcSEcCtD
Nepafenac—Ulcerative keratitis—Prednisone—systemic lupus erythematosus	0.00161	0.0137	CcSEcCtD
Nepafenac—Ocular discomfort—Methotrexate—systemic lupus erythematosus	0.0015	0.0127	CcSEcCtD
Nepafenac—Sensation of foreign body—Betamethasone—systemic lupus erythematosus	0.00144	0.0122	CcSEcCtD
Nepafenac—Sensation of foreign body—Dexamethasone—systemic lupus erythematosus	0.00144	0.0122	CcSEcCtD
Nepafenac—Conjunctival hyperaemia—Cyclosporine—systemic lupus erythematosus	0.0014	0.0119	CcSEcCtD
Nepafenac—Impaired healing—Mycophenolate mofetil—systemic lupus erythematosus	0.00139	0.0118	CcSEcCtD
Nepafenac—Impaired healing—Prednisolone—systemic lupus erythematosus	0.0013	0.011	CcSEcCtD
Nepafenac—Intraocular pressure increased—Prednisolone—systemic lupus erythematosus	0.00128	0.0108	CcSEcCtD
Nepafenac—Conjunctival hyperaemia—Prednisolone—systemic lupus erythematosus	0.00128	0.0108	CcSEcCtD
Nepafenac—Impaired healing—Hydrocortisone—systemic lupus erythematosus	0.00127	0.0107	CcSEcCtD
Nepafenac—Intraocular pressure increased—Hydrocortisone—systemic lupus erythematosus	0.00125	0.0106	CcSEcCtD
Nepafenac—Impaired healing—Triamcinolone—systemic lupus erythematosus	0.00119	0.0101	CcSEcCtD
Nepafenac—Impaired healing—Methylprednisolone—systemic lupus erythematosus	0.00119	0.0101	CcSEcCtD
Nepafenac—Intraocular pressure increased—Triamcinolone—systemic lupus erythematosus	0.00117	0.00995	CcSEcCtD
Nepafenac—Intraocular pressure increased—Methylprednisolone—systemic lupus erythematosus	0.00117	0.00993	CcSEcCtD
Nepafenac—Impaired healing—Betamethasone—systemic lupus erythematosus	0.00108	0.00918	CcSEcCtD
Nepafenac—Impaired healing—Dexamethasone—systemic lupus erythematosus	0.00108	0.00918	CcSEcCtD
Nepafenac—Conjunctival hyperaemia—Betamethasone—systemic lupus erythematosus	0.00106	0.00903	CcSEcCtD
Nepafenac—Conjunctival hyperaemia—Dexamethasone—systemic lupus erythematosus	0.00106	0.00903	CcSEcCtD
Nepafenac—Intraocular pressure increased—Dexamethasone—systemic lupus erythematosus	0.00106	0.00903	CcSEcCtD
Nepafenac—Intraocular pressure increased—Betamethasone—systemic lupus erythematosus	0.00106	0.00903	CcSEcCtD
Nepafenac—Endophthalmitis—Betamethasone—systemic lupus erythematosus	0.000983	0.00834	CcSEcCtD
Nepafenac—Endophthalmitis—Dexamethasone—systemic lupus erythematosus	0.000983	0.00834	CcSEcCtD
Nepafenac—Blepharitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000978	0.00829	CcSEcCtD
Nepafenac—Impaired healing—Prednisone—systemic lupus erythematosus	0.000943	0.00799	CcSEcCtD
Nepafenac—Keratitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000927	0.00786	CcSEcCtD
Nepafenac—Intraocular pressure increased—Prednisone—systemic lupus erythematosus	0.000927	0.00786	CcSEcCtD
Nepafenac—Keratitis—Prednisolone—systemic lupus erythematosus	0.000865	0.00734	CcSEcCtD
Nepafenac—Endophthalmitis—Prednisone—systemic lupus erythematosus	0.000856	0.00726	CcSEcCtD
Nepafenac—Cataract—Leflunomide—systemic lupus erythematosus	0.000839	0.00712	CcSEcCtD
Nepafenac—Blood pressure increased—Leflunomide—systemic lupus erythematosus	0.000799	0.00678	CcSEcCtD
Nepafenac—Impaired healing—Methotrexate—systemic lupus erythematosus	0.000788	0.00668	CcSEcCtD
Nepafenac—Visual acuity reduced—Betamethasone—systemic lupus erythematosus	0.000787	0.00667	CcSEcCtD
Nepafenac—Visual acuity reduced—Dexamethasone—systemic lupus erythematosus	0.000787	0.00667	CcSEcCtD
Nepafenac—Sinusitis—Dapsone—systemic lupus erythematosus	0.000785	0.00666	CcSEcCtD
Nepafenac—Blepharitis—Betamethasone—systemic lupus erythematosus	0.000761	0.00645	CcSEcCtD
Nepafenac—Blepharitis—Dexamethasone—systemic lupus erythematosus	0.000761	0.00645	CcSEcCtD
Nepafenac—Dermatitis atopic—Prednisolone—systemic lupus erythematosus	0.000758	0.00643	CcSEcCtD
Nepafenac—Keratitis—Betamethasone—systemic lupus erythematosus	0.000722	0.00612	CcSEcCtD
Nepafenac—Keratitis—Dexamethasone—systemic lupus erythematosus	0.000722	0.00612	CcSEcCtD
Nepafenac—Dermatitis atopic—Triamcinolone—systemic lupus erythematosus	0.000697	0.00591	CcSEcCtD
Nepafenac—Lacrimation increased—Cyclosporine—systemic lupus erythematosus	0.000669	0.00567	CcSEcCtD
Nepafenac—Diabetes mellitus—Leflunomide—systemic lupus erythematosus	0.000667	0.00565	CcSEcCtD
Nepafenac—Eye irritation—Prednisolone—systemic lupus erythematosus	0.000657	0.00557	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000652	0.159	CbGdCrCtD
Nepafenac—Cataract—Cyclosporine—systemic lupus erythematosus	0.000648	0.00549	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000642	0.156	CbGdCrCtD
Nepafenac—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000642	0.156	CbGdCrCtD
Nepafenac—Cataract—Mycophenolate mofetil—systemic lupus erythematosus	0.000632	0.00536	CcSEcCtD
Nepafenac—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000627	0.153	CbGdCrCtD
Nepafenac—Vision blurred—Dapsone—systemic lupus erythematosus	0.000616	0.00523	CcSEcCtD
Nepafenac—Arthritis—Leflunomide—systemic lupus erythematosus	0.000597	0.00506	CcSEcCtD
Nepafenac—Cataract—Hydrocortisone—systemic lupus erythematosus	0.000576	0.00488	CcSEcCtD
Nepafenac—Photophobia—Mycophenolate mofetil—systemic lupus erythematosus	0.000565	0.00479	CcSEcCtD
Nepafenac—Dermatitis atopic—Prednisone—systemic lupus erythematosus	0.000551	0.00467	CcSEcCtD
Nepafenac—Cataract—Triamcinolone—systemic lupus erythematosus	0.000542	0.0046	CcSEcCtD
Nepafenac—Diabetes mellitus—Cyclosporine—systemic lupus erythematosus	0.000515	0.00436	CcSEcCtD
Nepafenac—Dry eye—Hydrocortisone—systemic lupus erythematosus	0.000506	0.00429	CcSEcCtD
Nepafenac—Diabetes mellitus—Mycophenolate mofetil—systemic lupus erythematosus	0.000502	0.00426	CcSEcCtD
Nepafenac—Eye pain—Cyclosporine—systemic lupus erythematosus	0.000496	0.0042	CcSEcCtD
Nepafenac—Cataract—Betamethasone—systemic lupus erythematosus	0.000492	0.00417	CcSEcCtD
Nepafenac—Cataract—Dexamethasone—systemic lupus erythematosus	0.000492	0.00417	CcSEcCtD
Nepafenac—Eye pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000484	0.0041	CcSEcCtD
Nepafenac—PTGS1—endothelium—systemic lupus erythematosus	0.000482	0.11	CbGeAlD
Nepafenac—Diabetes mellitus—Prednisolone—systemic lupus erythematosus	0.000468	0.00397	CcSEcCtD
Nepafenac—PTGS2—endothelium—systemic lupus erythematosus	0.000461	0.105	CbGeAlD
Nepafenac—Arthritis—Cyclosporine—systemic lupus erythematosus	0.00046	0.00391	CcSEcCtD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.00046	0.0932	CbGpPWpGaD
Nepafenac—Diabetes mellitus—Hydrocortisone—systemic lupus erythematosus	0.000457	0.00388	CcSEcCtD
Nepafenac—Ketorolac—PTGS2—systemic lupus erythematosus	0.000436	0.114	CrCbGaD
Nepafenac—Dry eye—Betamethasone—systemic lupus erythematosus	0.000432	0.00367	CcSEcCtD
Nepafenac—Dry eye—Dexamethasone—systemic lupus erythematosus	0.000432	0.00367	CcSEcCtD
Nepafenac—Diabetes mellitus—Triamcinolone—systemic lupus erythematosus	0.000431	0.00365	CcSEcCtD
Nepafenac—Diabetes mellitus—Methylprednisolone—systemic lupus erythematosus	0.00043	0.00364	CcSEcCtD
Nepafenac—Cataract—Prednisone—systemic lupus erythematosus	0.000428	0.00363	CcSEcCtD
Nepafenac—PTGS1—blood plasma—systemic lupus erythematosus	0.000428	0.0978	CbGeAlD
Nepafenac—Sinusitis—Leflunomide—systemic lupus erythematosus	0.000419	0.00356	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—systemic lupus erythematosus	0.000418	0.109	CrCbGaD
Nepafenac—PTGS2—blood plasma—systemic lupus erythematosus	0.000409	0.0935	CbGeAlD
Nepafenac—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000394	0.0958	CbGdCrCtD
Nepafenac—Diabetes mellitus—Betamethasone—systemic lupus erythematosus	0.000391	0.00331	CcSEcCtD
Nepafenac—Diabetes mellitus—Dexamethasone—systemic lupus erythematosus	0.000391	0.00331	CcSEcCtD
Nepafenac—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000387	0.0943	CbGdCrCtD
Nepafenac—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000387	0.0943	CbGdCrCtD
Nepafenac—Immune system disorder—Azathioprine—systemic lupus erythematosus	0.000384	0.00325	CcSEcCtD
Nepafenac—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000379	0.0921	CbGdCrCtD
Nepafenac—Eye pain—Dexamethasone—systemic lupus erythematosus	0.000376	0.00319	CcSEcCtD
Nepafenac—Eye pain—Betamethasone—systemic lupus erythematosus	0.000376	0.00319	CcSEcCtD
Nepafenac—Eye disorder—Leflunomide—systemic lupus erythematosus	0.000375	0.00318	CcSEcCtD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.000365	0.074	CbGpPWpGaD
Nepafenac—Immune system disorder—Leflunomide—systemic lupus erythematosus	0.000362	0.00307	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS2—systemic lupus erythematosus	0.000355	0.0931	CrCbGaD
Nepafenac—Diabetes mellitus—Prednisone—systemic lupus erythematosus	0.00034	0.00289	CcSEcCtD
Nepafenac—Vomiting—Dapsone—systemic lupus erythematosus	0.000339	0.00288	CcSEcCtD
Nepafenac—Headache—Dapsone—systemic lupus erythematosus	0.000334	0.00284	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—systemic lupus erythematosus	0.00033	0.0865	CrCbGaD
Nepafenac—Vision blurred—Leflunomide—systemic lupus erythematosus	0.000329	0.00279	CcSEcCtD
Nepafenac—Sinusitis—Cyclosporine—systemic lupus erythematosus	0.000324	0.00274	CcSEcCtD
Nepafenac—Fenbufen—PTGS2—systemic lupus erythematosus	0.000323	0.0847	CrCbGaD
Nepafenac—Nausea—Dapsone—systemic lupus erythematosus	0.000317	0.00269	CcSEcCtD
Nepafenac—Sinusitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000316	0.00268	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.000313	0.00265	CcSEcCtD
Nepafenac—Hypertension—Leflunomide—systemic lupus erythematosus	0.000302	0.00256	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.000295	0.0025	CcSEcCtD
Nepafenac—Magnesium salicylate—ALB—systemic lupus erythematosus	0.000294	0.0771	CrCbGaD
Nepafenac—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000293	0.00249	CcSEcCtD
Nepafenac—Dry mouth—Leflunomide—systemic lupus erythematosus	0.000291	0.00247	CcSEcCtD
Nepafenac—Diabetes mellitus—Methotrexate—systemic lupus erythematosus	0.000284	0.00241	CcSEcCtD
Nepafenac—Eye disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000282	0.00239	CcSEcCtD
Nepafenac—Angiopathy—Cyclosporine—systemic lupus erythematosus	0.000281	0.00238	CcSEcCtD
Nepafenac—Salsalate—PTGS2—systemic lupus erythematosus	0.000281	0.0736	CrCbGaD
Nepafenac—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.00028	0.00237	CcSEcCtD
Nepafenac—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000277	0.00235	CcSEcCtD
Nepafenac—Angiopathy—Mycophenolate mofetil—systemic lupus erythematosus	0.000274	0.00232	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000261	0.00221	CcSEcCtD
Nepafenac—Eye disorder—Hydrocortisone—systemic lupus erythematosus	0.000257	0.00218	CcSEcCtD
Nepafenac—Vision blurred—Cyclosporine—systemic lupus erythematosus	0.000254	0.00215	CcSEcCtD
Nepafenac—Immune system disorder—Hydrocortisone—systemic lupus erythematosus	0.000249	0.00211	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000246	0.00209	CcSEcCtD
Nepafenac—Eye disorder—Methylprednisolone—systemic lupus erythematosus	0.000242	0.00205	CcSEcCtD
Nepafenac—Angiopathy—Methylprednisolone—systemic lupus erythematosus	0.000235	0.00199	CcSEcCtD
Nepafenac—Immune system disorder—Methylprednisolone—systemic lupus erythematosus	0.000233	0.00198	CcSEcCtD
Nepafenac—Hypertension—Cyclosporine—systemic lupus erythematosus	0.000233	0.00197	CcSEcCtD
Nepafenac—Fenoprofen—PTGS2—systemic lupus erythematosus	0.000232	0.0608	CrCbGaD
Nepafenac—Vision blurred—Prednisolone—systemic lupus erythematosus	0.000231	0.00196	CcSEcCtD
Nepafenac—PTGS1—connective tissue—systemic lupus erythematosus	0.000228	0.0521	CbGeAlD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000228	0.00193	CcSEcCtD
Nepafenac—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000227	0.00193	CcSEcCtD
Nepafenac—Dry mouth—Cyclosporine—systemic lupus erythematosus	0.000224	0.0019	CcSEcCtD
Nepafenac—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000222	0.00189	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000222	0.00189	CcSEcCtD
Nepafenac—Eye disorder—Betamethasone—systemic lupus erythematosus	0.00022	0.00186	CcSEcCtD
Nepafenac—Eye disorder—Dexamethasone—systemic lupus erythematosus	0.00022	0.00186	CcSEcCtD
Nepafenac—Dry mouth—Mycophenolate mofetil—systemic lupus erythematosus	0.000219	0.00186	CcSEcCtD
Nepafenac—PTGS2—connective tissue—systemic lupus erythematosus	0.000218	0.0498	CbGeAlD
Nepafenac—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000216	0.00183	CcSEcCtD
Nepafenac—Mefenamic acid—PTGS2—systemic lupus erythematosus	0.000215	0.0564	CrCbGaD
Nepafenac—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000214	0.00181	CcSEcCtD
Nepafenac—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.000213	0.00181	CcSEcCtD
Nepafenac—Angiopathy—Betamethasone—systemic lupus erythematosus	0.000213	0.00181	CcSEcCtD
Nepafenac—Hypertension—Prednisolone—systemic lupus erythematosus	0.000212	0.0018	CcSEcCtD
Nepafenac—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00021	0.00178	CcSEcCtD
Nepafenac—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.00021	0.00178	CcSEcCtD
Nepafenac—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000208	0.00177	CcSEcCtD
Nepafenac—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000207	0.00175	CcSEcCtD
Nepafenac—Fenoprofen—ALB—systemic lupus erythematosus	0.000207	0.0542	CrCbGaD
Nepafenac—PTGS1—skin of body—systemic lupus erythematosus	0.000206	0.047	CbGeAlD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000203	0.00172	CcSEcCtD
Nepafenac—Pruritus—Leflunomide—systemic lupus erythematosus	0.000202	0.00171	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—systemic lupus erythematosus	0.000201	0.0407	CbGpPWpGaD
Nepafenac—Dizziness—Azathioprine—systemic lupus erythematosus	0.0002	0.00169	CcSEcCtD
Nepafenac—PTGS2—skin of body—systemic lupus erythematosus	0.000197	0.0449	CbGeAlD
Nepafenac—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000195	0.00165	CcSEcCtD
Nepafenac—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000194	0.00165	CcSEcCtD
Nepafenac—PTGS1—kidney—systemic lupus erythematosus	0.000194	0.0443	CbGeAlD
Nepafenac—Vomiting—Azathioprine—systemic lupus erythematosus	0.000192	0.00163	CcSEcCtD
Nepafenac—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000192	0.00163	CcSEcCtD
Nepafenac—Eye disorder—Prednisone—systemic lupus erythematosus	0.000191	0.00162	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.00019	0.00161	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.00019	0.00161	CcSEcCtD
Nepafenac—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.00019	0.00161	CcSEcCtD
Nepafenac—Headache—Azathioprine—systemic lupus erythematosus	0.000189	0.0016	CcSEcCtD
Nepafenac—Dizziness—Leflunomide—systemic lupus erythematosus	0.000188	0.0016	CcSEcCtD
Nepafenac—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000188	0.00159	CcSEcCtD
Nepafenac—Angiopathy—Prednisone—systemic lupus erythematosus	0.000186	0.00158	CcSEcCtD
Nepafenac—PTGS2—kidney—systemic lupus erythematosus	0.000185	0.0424	CbGeAlD
Nepafenac—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000185	0.00157	CcSEcCtD
Nepafenac—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000185	0.00157	CcSEcCtD
Nepafenac—Vomiting—Leflunomide—systemic lupus erythematosus	0.000181	0.00154	CcSEcCtD
Nepafenac—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.00018	0.00153	CcSEcCtD
Nepafenac—Nausea—Azathioprine—systemic lupus erythematosus	0.000179	0.00152	CcSEcCtD
Nepafenac—Headache—Leflunomide—systemic lupus erythematosus	0.000179	0.00151	CcSEcCtD
Nepafenac—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000178	0.00151	CcSEcCtD
Nepafenac—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000177	0.0015	CcSEcCtD
Nepafenac—Hypertension—Betamethasone—systemic lupus erythematosus	0.000177	0.0015	CcSEcCtD
Nepafenac—PTGS2—C-MYB transcription factor network—PRTN3—systemic lupus erythematosus	0.000175	0.0355	CbGpPWpGaD
Nepafenac—Oxcarbazepine—ALB—systemic lupus erythematosus	0.000173	0.0454	CrCbGaD
Nepafenac—Nausea—Leflunomide—systemic lupus erythematosus	0.000169	0.00144	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000169	0.00143	CcSEcCtD
Nepafenac—Vision blurred—Prednisone—systemic lupus erythematosus	0.000168	0.00142	CcSEcCtD
Nepafenac—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000164	0.00139	CcSEcCtD
Nepafenac—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000164	0.00139	CcSEcCtD
Nepafenac—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000162	0.00137	CcSEcCtD
Nepafenac—Eye disorder—Methotrexate—systemic lupus erythematosus	0.00016	0.00136	CcSEcCtD
Nepafenac—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000159	0.0364	CbGeAlD
Nepafenac—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000158	0.00134	CcSEcCtD
Nepafenac—PTGS1—tendon—systemic lupus erythematosus	0.000157	0.0358	CbGeAlD
Nepafenac—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000156	0.00132	CcSEcCtD
Nepafenac—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000155	0.00132	CcSEcCtD
Nepafenac—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000155	0.00131	CcSEcCtD
Nepafenac—Diclofenac—PTGS2—systemic lupus erythematosus	0.000155	0.0405	CrCbGaD
Nepafenac—Hypertension—Prednisone—systemic lupus erythematosus	0.000154	0.0013	CcSEcCtD
Nepafenac—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000152	0.00129	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000151	0.00128	CcSEcCtD
Nepafenac—PTGS2—Spinal Cord Injury—TNFSF13B—systemic lupus erythematosus	0.00015	0.0303	CbGpPWpGaD
Nepafenac—PTGS2—tendon—systemic lupus erythematosus	0.00015	0.0342	CbGeAlD
Nepafenac—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000147	0.00125	CcSEcCtD
Nepafenac—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000145	0.00123	CcSEcCtD
Nepafenac—PTGS2—bone marrow—systemic lupus erythematosus	0.000145	0.0331	CbGeAlD
Nepafenac—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000144	0.00122	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000144	0.00122	CcSEcCtD
Nepafenac—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000144	0.00122	CcSEcCtD
Nepafenac—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000143	0.00121	CcSEcCtD
Nepafenac—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000142	0.0012	CcSEcCtD
Nepafenac—Skin disorder—Prednisone—systemic lupus erythematosus	0.000141	0.0012	CcSEcCtD
Nepafenac—Vision blurred—Methotrexate—systemic lupus erythematosus	0.00014	0.00119	CcSEcCtD
Nepafenac—Vomiting—Cyclosporine—systemic lupus erythematosus	0.00014	0.00119	CcSEcCtD
Nepafenac—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000138	0.00117	CcSEcCtD
Nepafenac—Headache—Cyclosporine—systemic lupus erythematosus	0.000138	0.00117	CcSEcCtD
Nepafenac—Diclofenac—ALB—systemic lupus erythematosus	0.000138	0.0361	CrCbGaD
Nepafenac—PTGS1—lung—systemic lupus erythematosus	0.000138	0.0314	CbGeAlD
Nepafenac—Ketoprofen—PTGS2—systemic lupus erythematosus	0.000137	0.0359	CrCbGaD
Nepafenac—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000136	0.00116	CcSEcCtD
Nepafenac—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000136	0.00115	CcSEcCtD
Nepafenac—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000135	0.00115	CcSEcCtD
Nepafenac—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.00114	CcSEcCtD
Nepafenac—Dizziness—Prednisolone—systemic lupus erythematosus	0.000132	0.00112	CcSEcCtD
Nepafenac—PTGS2—lung—systemic lupus erythematosus	0.000131	0.03	CbGeAlD
Nepafenac—Nausea—Cyclosporine—systemic lupus erythematosus	0.000131	0.00111	CcSEcCtD
Nepafenac—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00013	0.0011	CcSEcCtD
Nepafenac—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.00013	0.0011	CcSEcCtD
Nepafenac—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000129	0.0011	CcSEcCtD
Nepafenac—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000127	0.00108	CcSEcCtD
Nepafenac—PTGS1—nervous system—systemic lupus erythematosus	0.000127	0.0291	CbGeAlD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000126	0.00107	CcSEcCtD
Nepafenac—Headache—Prednisolone—systemic lupus erythematosus	0.000125	0.00106	CcSEcCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000125	0.0253	CbGpPWpGaD
Nepafenac—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000124	0.00105	CcSEcCtD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000123	0.0249	CbGpPWpGaD
Nepafenac—PTGS1—central nervous system—systemic lupus erythematosus	0.000123	0.028	CbGeAlD
Nepafenac—Headache—Hydrocortisone—systemic lupus erythematosus	0.000122	0.00104	CcSEcCtD
Nepafenac—Ketoprofen—ALB—systemic lupus erythematosus	0.000122	0.032	CrCbGaD
Nepafenac—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000122	0.00103	CcSEcCtD
Nepafenac—PTGS2—nervous system—systemic lupus erythematosus	0.000122	0.0278	CbGeAlD
Nepafenac—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000121	0.00103	CcSEcCtD
Nepafenac—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000119	0.00101	CcSEcCtD
Nepafenac—Nausea—Prednisolone—systemic lupus erythematosus	0.000119	0.00101	CcSEcCtD
Nepafenac—Pruritus—Betamethasone—systemic lupus erythematosus	0.000118	0.001	CcSEcCtD
Nepafenac—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000118	0.001	CcSEcCtD
Nepafenac—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000118	0.001	CcSEcCtD
Nepafenac—PTGS2—central nervous system—systemic lupus erythematosus	0.000117	0.0268	CbGeAlD
Nepafenac—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000117	0.000993	CcSEcCtD
Nepafenac—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000117	0.00099	CcSEcCtD
Nepafenac—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000116	0.000985	CcSEcCtD
Nepafenac—Headache—Triamcinolone—systemic lupus erythematosus	0.000115	0.000978	CcSEcCtD
Nepafenac—Headache—Methylprednisolone—systemic lupus erythematosus	0.000115	0.000976	CcSEcCtD
Nepafenac—Dizziness—Dexamethasone—systemic lupus erythematosus	0.00011	0.000937	CcSEcCtD
Nepafenac—Dizziness—Betamethasone—systemic lupus erythematosus	0.00011	0.000937	CcSEcCtD
Nepafenac—Nausea—Triamcinolone—systemic lupus erythematosus	0.000109	0.000927	CcSEcCtD
Nepafenac—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000925	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—systemic lupus erythematosus	0.000109	0.0221	CbGpPWpGaD
Nepafenac—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000107	0.000909	CcSEcCtD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	0.000107	0.0217	CbGpPWpGaD
Nepafenac—Vomiting—Betamethasone—systemic lupus erythematosus	0.000106	0.000901	CcSEcCtD
Nepafenac—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000106	0.000901	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000105	0.00089	CcSEcCtD
Nepafenac—Headache—Betamethasone—systemic lupus erythematosus	0.000105	0.000887	CcSEcCtD
Nepafenac—Headache—Dexamethasone—systemic lupus erythematosus	0.000105	0.000887	CcSEcCtD
Nepafenac—Pruritus—Prednisone—systemic lupus erythematosus	0.000103	0.000873	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	0.000102	0.0206	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	9.93e-05	0.0201	CbGpPWpGaD
Nepafenac—Nausea—Betamethasone—systemic lupus erythematosus	9.92e-05	0.000841	CcSEcCtD
Nepafenac—Nausea—Dexamethasone—systemic lupus erythematosus	9.92e-05	0.000841	CcSEcCtD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	9.78e-05	0.0198	CbGpPWpGaD
Nepafenac—Dizziness—Prednisone—systemic lupus erythematosus	9.62e-05	0.000816	CcSEcCtD
Nepafenac—Vomiting—Prednisone—systemic lupus erythematosus	9.25e-05	0.000784	CcSEcCtD
Nepafenac—Headache—Prednisone—systemic lupus erythematosus	9.11e-05	0.000773	CcSEcCtD
Nepafenac—Hypersensitivity—Methotrexate—systemic lupus erythematosus	8.96e-05	0.00076	CcSEcCtD
Nepafenac—Nausea—Prednisone—systemic lupus erythematosus	8.64e-05	0.000733	CcSEcCtD
Nepafenac—Pruritus—Methotrexate—systemic lupus erythematosus	8.6e-05	0.000729	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic lupus erythematosus	8.42e-05	0.017	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	8.39e-05	0.017	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—systemic lupus erythematosus	8.19e-05	0.0166	CbGpPWpGaD
Nepafenac—Dizziness—Methotrexate—systemic lupus erythematosus	8.04e-05	0.000682	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—systemic lupus erythematosus	7.83e-05	0.0158	CbGpPWpGaD
Nepafenac—Vomiting—Methotrexate—systemic lupus erythematosus	7.73e-05	0.000655	CcSEcCtD
Nepafenac—Headache—Methotrexate—systemic lupus erythematosus	7.62e-05	0.000646	CcSEcCtD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—systemic lupus erythematosus	7.51e-05	0.0152	CbGpPWpGaD
Nepafenac—Nausea—Methotrexate—systemic lupus erythematosus	7.22e-05	0.000612	CcSEcCtD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	7.05e-05	0.0143	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	7e-05	0.0142	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	6.96e-05	0.0141	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	6.52e-05	0.0132	CbGpPWpGaD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	6.02e-05	0.0122	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	5.82e-05	0.0118	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	5.78e-05	0.0117	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	5.66e-05	0.0115	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	5.46e-05	0.011	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	5.45e-05	0.011	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	5.3e-05	0.0107	CbGpPWpGaD
Nepafenac—PTGS2—S1P1 pathway—VEGFA—systemic lupus erythematosus	5.24e-05	0.0106	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	5.17e-05	0.0105	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	5.06e-05	0.0102	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	4.95e-05	0.01	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	4.85e-05	0.00982	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	4.57e-05	0.00925	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	4.5e-05	0.0091	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	4.44e-05	0.00898	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	4.4e-05	0.00891	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	3.9e-05	0.0079	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.87e-05	0.00783	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	3.76e-05	0.00762	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	3.67e-05	0.00743	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	3.63e-05	0.00734	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	3.39e-05	0.00685	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	3.2e-05	0.00648	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	3.11e-05	0.00629	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	3.02e-05	0.00611	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	2.91e-05	0.0059	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	2.9e-05	0.00587	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	2.87e-05	0.00581	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	2.85e-05	0.00576	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	2.81e-05	0.00569	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.73e-05	0.00552	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	2.69e-05	0.00544	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	2.67e-05	0.00539	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.59e-05	0.00523	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	2.57e-05	0.00519	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	2.56e-05	0.00518	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	2.46e-05	0.00498	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	2.41e-05	0.00489	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.4e-05	0.00485	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	2.23e-05	0.00452	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.22e-05	0.00448	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	2.21e-05	0.00447	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	2.12e-05	0.00428	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	2.07e-05	0.0042	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	2.04e-05	0.00413	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	2.04e-05	0.00412	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	1.92e-05	0.00389	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	1.9e-05	0.00384	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	1.77e-05	0.00359	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.73e-05	0.00351	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	1.69e-05	0.00341	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.67e-05	0.00338	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.66e-05	0.00336	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	1.61e-05	0.00326	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	1.46e-05	0.00296	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	1.43e-05	0.0029	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	1.36e-05	0.00274	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.34e-05	0.00271	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.32e-05	0.00267	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	1.12e-05	0.00226	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.11e-05	0.00225	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.06e-05	0.00215	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	1.04e-05	0.00211	CbGpPWpGaD
Nepafenac—PTGS2—Disease—XRCC6—systemic lupus erythematosus	1.04e-05	0.0021	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	9.95e-06	0.00201	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	9.19e-06	0.00186	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	8.84e-06	0.00179	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.83e-06	0.00179	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	8.74e-06	0.00177	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	8.42e-06	0.0017	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	8.28e-06	0.00168	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	7.67e-06	0.00155	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	7.6e-06	0.00154	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CSK—systemic lupus erythematosus	7.47e-06	0.00151	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	7.09e-06	0.00144	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.03e-06	0.00142	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD247—systemic lupus erythematosus	7.02e-06	0.00142	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	7.02e-06	0.00142	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NCF2—systemic lupus erythematosus	6.83e-06	0.00138	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.32e-06	0.00128	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.58e-06	0.00113	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.53e-06	0.00112	CbGpPWpGaD
Nepafenac—PTGS2—Disease—JUNB—systemic lupus erythematosus	5.36e-06	0.00109	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.02e-06	0.00102	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	4.96e-06	0.001	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRL—systemic lupus erythematosus	4.94e-06	0.001	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.6e-06	0.00093	CbGpPWpGaD
Nepafenac—PTGS2—Disease—JAK1—systemic lupus erythematosus	3.95e-06	0.0008	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	3.93e-06	0.000796	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CCR5—systemic lupus erythematosus	3.74e-06	0.000758	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.65e-06	0.000739	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	3.13e-06	0.000633	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD80—systemic lupus erythematosus	3.08e-06	0.000623	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—systemic lupus erythematosus	2.81e-06	0.00057	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	2.69e-06	0.000545	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TYK2—systemic lupus erythematosus	2.6e-06	0.000526	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—systemic lupus erythematosus	2.55e-06	0.000516	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	2.48e-06	0.000503	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	2.46e-06	0.000498	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD4—systemic lupus erythematosus	2.35e-06	0.000476	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—systemic lupus erythematosus	2.23e-06	0.000452	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	2.21e-06	0.000447	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	2.14e-06	0.000432	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—EP300—systemic lupus erythematosus	2.05e-06	0.000414	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	2.04e-06	0.000413	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EP300—systemic lupus erythematosus	1.94e-06	0.000393	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—systemic lupus erythematosus	1.69e-06	0.000341	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—EP300—systemic lupus erythematosus	1.63e-06	0.000329	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—systemic lupus erythematosus	1.27e-06	0.000257	CbGpPWpGaD
